These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16206577)

  • 1. [Brain protection during ischemia: state-of-the-art].
    Babaian E; Zel'man VL; Polushin IuS; Shchegolev AV
    Anesteziol Reanimatol; 2005; (4):4-14. PubMed ID: 16206577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemia and ischemic tolerance in the brain: an overview.
    Zemke D; Smith JL; Reeves MJ; Majid A
    Neurotoxicology; 2004 Dec; 25(6):895-904. PubMed ID: 15474608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurotoxicity, neuroprotection and therapeutic window in cerebral ischemia].
    Mostacero E
    Rev Neurol; 1999 Sep 16-30; 29(6):513-4. PubMed ID: 10584264
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene expression in cerebral ischemia: a new approach for neuroprotection.
    Millán M; Arenillas J
    Cerebrovasc Dis; 2006; 21 Suppl 2():30-7. PubMed ID: 16651812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids modulate post-ischemic progression in a rat model of stroke.
    Kao TK; Ou YC; Liao SL; Chen WY; Wang CC; Chen SY; Chiang AN; Chen CJ
    Neurochem Int; 2008 May; 52(6):1256-65. PubMed ID: 18294735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotection by nitrous oxide: facts and evidence.
    Haelewyn B; David HN; Rouillon C; Chazalviel L; Lecocq M; Risso JJ; Lemaire M; Abraini JH
    Crit Care Med; 2008 Sep; 36(9):2651-9. PubMed ID: 18679119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postischemic treatment of neonatal cerebral ischemia should target autophagy.
    Puyal J; Vaslin A; Mottier V; Clarke PG
    Ann Neurol; 2009 Sep; 66(3):378-89. PubMed ID: 19551849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective potential of group I metabotropic glutamate receptor antagonists in two ischemic models.
    Makarewicz D; Duszczyk M; Gadamski R; Danysz W; Łazarewicz JW
    Neurochem Int; 2006; 48(6-7):485-90. PubMed ID: 16513218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation.
    Kaundal RK; Shah KK; Sharma SS
    Life Sci; 2006 Nov; 79(24):2293-302. PubMed ID: 16935310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental models of cerebral ischemia].
    Prieto-Arribas R; Moreno-Gutiérrez A; Simal-Hernández P; Pascual-Garvi JM; Matías-Guiu J; Roda JM; Barcia-Albacar JA
    Rev Neurol; 2008 Oct 16-31; 47(8):414-26. PubMed ID: 18937203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrous oxide: from neurotoxicity to neuroprotection?
    Bracco D; Hemmerling TM
    Crit Care Med; 2008 Sep; 36(9):2705-6. PubMed ID: 18728494
    [No Abstract]   [Full Text] [Related]  

  • 12. For ischemic brain damage, is preclinical evidence of neuroprotection by presynaptic blockade of glutamate release enough?
    Nava-Ocampo AA; Reyes-Pérez H; Bello-Ramírez AM; Mansilla-Olivares A; Ponce-Monter H
    Med Hypotheses; 2000 Jan; 54(1):77-9. PubMed ID: 10790730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral protection and resuscitation in the liver transplant recipient.
    Plevak DJ
    Liver Transpl Surg; 1999 Jul; 5(4):351-2. PubMed ID: 10388513
    [No Abstract]   [Full Text] [Related]  

  • 14. [Brain protection by anesthetics].
    Adachi N
    Masui; 2006 May; 55(5):542-51. PubMed ID: 16715908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anesthetics and brain protection.
    Head BP; Patel P
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):395-9. PubMed ID: 17873591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential neuroprotective drugs in cerebral ischemia: new saturated and polyunsaturated lipids coupled to hydrophilic moieties: synthesis and biological activity.
    Biraboneye AC; Madonna S; Laras Y; Krantic S; Maher P; Kraus JL
    J Med Chem; 2009 Jul; 52(14):4358-69. PubMed ID: 19537799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic hypothermia for global and focal ischemic brain injury--a cool way to improve neurologic outcomes.
    Hoesch RE; Geocadin RG
    Neurologist; 2007 Nov; 13(6):331-42. PubMed ID: 18090711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanism of ischemic brain injuries and perspectives of drug therapies for neuroprotection].
    Uchino H; Morota S; Hirabayashi G; Ushijima K; Kakinuma T; Ishii N; Shibasaki F; Kuroda Y
    Masui; 2007 Mar; 56(3):248-70. PubMed ID: 17366913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia.
    Liang S; Pong K; Gonzales C; Chen Y; Ling HP; Mark RJ; Boschelli F; Boschelli DH; Ye F; Barrios Sosa AC; Mansour TS; Frost P; Wood A; Pangalos MN; Zaleska MM
    J Pharmacol Exp Ther; 2009 Dec; 331(3):827-35. PubMed ID: 19741150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous inhibition of 20-HETE synthesis by TS-011 improves neurological and functional outcomes after transient focal cerebral ischemia in rats.
    Tanaka Y; Omura T; Fukasawa M; Horiuchi N; Miyata N; Minagawa T; Yoshida S; Nakaike S
    Neurosci Res; 2007 Dec; 59(4):475-80. PubMed ID: 17933409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.